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must be anchored in aneurysm-free arterial segments.
However, aneurysmal dilatation of the artery may involve
essential aortic branches such as the renal or subclavian
arteries precluding endovascular repair.
In patients who exhibit one or more of these anatomic
limitations, endovascular repair may only be made possible
by the performance of adjunctive measures. This study was
designed to address three main issues: (1) to evaluate the
incidence and delineate the measures used to overcome
femoroiliac arterial disease as a significant impeding factor
to adequate endograft insertion for the treatment of tho-
racic and abdominal aortic aneurysms (AAAs), (2) to
describe the various adjunctive maneuvers used to enhance
endograft implantation sites by either creating or extend-
ing the stent-graft landing zones and to describe the over-
all incidence of patients requiring these maneuvers, and
(3) to provide a detailed description of the various auxil-
iary maneuvers needed in this series of patients to circum-
vent these initial obstacles and make these patients eligible
for endovascular stent-graft therapy.
Successful endovascular repair of aortic aneurysms has
ignited great enthusiasm because of the minimally invasive
aspects of this therapeutic modality.1 Delivery of the
endovascular device to the aneurysm from a remote arte-
rial site requires use of the iliac and femoral arteries for
access. These vessels are frequently diseased and may
require intervention before the endovascular device can be
accommodated. Furthermore, for complete aneurysm
exclusion and durable repair to be achieved, the stent-graft
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Purpose: The ability to treat abdominal aortoiliac aneurysms and thoracic aortic aneurysms may be limited by coexist-
ing arterial disease. Device deployment may be impaired by occlusive disease and tortuosity of the arteries used to access
the aneurysm or by suitability of the implantation sites. In this study we describe the auxiliary procedures performed
to circumvent these obstacles and thereby enable endovascular aneurysm repair.
Patients and Methods: Between January 1, 1993, and December 31, 1999, 390 patients treated for aneurysm of the aorta
with endovascular devices were entered prospectively in a vascular registry. Fifty (12%) of the 390 patients required
adjunctive surgical techniques to (1) create or extend the length of the proximal or distal device implantation site or
(2) permit device navigation through diseased iliac arteries. Auxiliary techniques used to extend or enhance implanta-
tion sites were elephant trunk graft (n = 2), the construction of renovisceral bypass grafts (n = 1), and subclavian artery
transposition (n = 2). Plication of the common iliac artery at its bifurcation was performed in conjunction with femo-
rofemoral bypass graft in nine patients to allow preservation of pelvic circulation by avoiding internal iliac artery sac-
rifice. Construction of a bypass graft to transpose the internal iliac artery orifice was performed in one patient. The
auxiliary techniques used to facilitate device navigation were iliac artery angioplasty or stenting (n = 8), external iliac
artery endovascular endarterectomy or straightening (n = 14), endoluminal iliofemoral bypass conduit (n = 5), and the
construction of an open iliofemoral bypass conduit (n = 8).
Results: Successful deployment of the endovascular devices was achieved in 49 (98%) of 50 patients. Auxiliary tech-
niques were successful in providing access for endovascular device deployment in all 35 patients (100%). Mean follow-
up for techniques to facilitate device navigation is 26 months for endovascular procedures and 42 months for the open
bypass graft construction patients; no occlusions were observed at this moment. There were five patients with incisional
hematomas that did not necessitate intervention. Fourteen (94%) of 15 patients underwent successful device implanta-
tion after the auxiliary maneuvers to enhance implantation site. Mean follow-up for implantation site manipulation is
28 months. One of the subclavian transpositions had a new onset of Horner’s syndrome, two of nine patients who had
common iliac artery ligated had retroperitoneal hematomas that did not necessitate interventions, and no colon
ischemia was seen. The patient who underwent nonanatomic bypass grafting of viscero-renal arteries had a retroperi-
toneal hematoma that necessitated reexploration. 
Conclusions: Significant coexisting arterial disease may be encountered in patients with aortic or iliac aneurysms.
Identification of coexisting arterial diseases is essential to help tailor the appropriate supplemental surgical procedure
to allow the performance of endovascular aneurysm repair in patients who would otherwise require open surgical
repair. (J Vasc Surg 2001;34:69-75.)
PATIENTS AND METHODS
Demographics
From January 1, 1993, to December 31, 1999, 390
patients with aortic and aortoiliac artery aneurysms were
treated with endovascular stent-grafts. Of the 390
patients, 50, or 12%, required adjunctive vascular proce-
dures to enable endovascular exclusion of their aneurysm.
All data about each patient were recorded prospectively in
vascular registry. The mean age was 76 years; 85% were
men.
Endovascular devices
The devices used in patients requiring adjunctive sur-
gical procedures were Talent (WorldMedical, Fort
Lauderdale, Fla), Gore Excluder–Thoracic and Abdominal
(Gore Inc, Sunnyvale, Calif), Vanguard (Boston Scientific,
San Jose, Mass), AneuRx (Medtronics, Calif), and Parodi-
type (custom-made device described elsewhere). In addi-
tion, all devices under investigation were performed with
industry-sponsored IDE protocol under the guidelines of
our institutional review board committee.
Auxiliary therapeutic modalities
Facilitating endovascular device delivery. The main
factors prompting the use of auxiliary techniques were
access vessel tortuosity or the presence of occlusive dis-
ease. The following maneuvers are described according to
the various arterial diseases and their corresponding inter-
ventions used to correct the lesion:
1. Iliac artery angioplasty. Eight patients with short seg-
ment stenotic iliac lesions were treated with balloon
angioplasty of the iliac vessels before stent-graft inser-
tion. After endograft deployment, a 10- to 12-mm
Wallstent (Wallstent, Schneider; Boston Scientific
Corp, Natick, Mass) was deployed in the predilated
segment to prevent arterial recoil. 
2. Endoluminal balloon endarterectomy. Extensive
external iliac artery stenosis was treated with endolu-
minal balloon endarterectomy2 in five patients. The
technique uses multiple balloon inflations throughout
the occlusive external iliac arterial segment with
removal of atheromatous debris through the femoral
arteriotomy site (Figure, A). Subsequent stent inser-
tion was used to prevent arterial restenosis. 
3. Endoluminal conduit. An endoluminal polytetrafluo-
roethylene (PTFE) conduit was used in five patients
with long-segment external iliac artery stenosis,3 in
whom endoluminal endarterectomy carried a high risk
for arterial rupture. A Palmaz stent (Cordis; Johnson
and Johnson Interventional Systems, Warren, NJ) was
sutured into a 6-mm PTFE conduit and backloaded
into a 6F device system. The Palmaz stent was
deployed over the orifice of the internal iliac artery
with the graft extending to the external iliac artery.
The entire length of the external iliac artery was then
dilated from within the PTFE graft with noncompliant
(6-8 mm in diameter [Diamond, Boston Scientific])
(Figure, B). The endoluminal conduit was implanted
into the distal external iliac artery in two cases, and an
endoluminal handsewn anastomosis in the common
femoral artery was used in the remaining three cases.4
4. External iliac artery straightening. For tortuous exter-
nal iliac arteries, manual retroperitoneal dissection was
used to straighten the redundant arterial segment in
nine cases. Once mobilized, the redundant and tortu-
ous segment was excised. 
5. Iliofemoral bypass conduit. In six patients, with severe
occlusive disease associated with marked tortuosity
involving the entire length of the iliac artery, an
iliofemoral bypass graft was constructed through a
retroperitoneal incision. The extraluminal iliofemoral
bypass conduit served to improve lower extremity
arterial flow and to allow device navigation to the
aorta through the bypass conduit. An iliofemoral
bypass conduit was also constructed in two additional
patients with small caliber external iliac arteries (< 5
mm in transverse diameter). In these patients, the
bypass graft was removed after endovascular aneurysm
exclusion by the stent-graft.
Implantation site modification. Modification of the
proximal and distal implantation sites was categorized into
two groups: manipulating directly to enhance the target
site to achieve a complete seal of the aneurysm by the
device or bypassing essential aortic branches, thereby
extending the inadequate neck to a proximal, more favor-
able aortic segment. Each of the specific anatomic presen-
tations and their corresponding maneuvers are described
below.
1. Preservation of pelvic arterial blood flow in patients
with bilateral iliac artery aneurysms. In nine patients
with AAAs with extension to the common iliac arter-
ies, an aortouniiliac endograft was performed with
embolization of the ipsilateral internal iliac artery. This
maneuver involves plication and division of the iliac
bifurcation via the retroperitoneal approach to allow
retrograde filling through the femorofemoral bypass
graft to the patent internal iliac artery. Another patient
had a bilateral internal iliac artery orifice relocated to
a distal portion to allow stent-graft implantation in the
external iliac artery segment.5 This patient had a his-
tory of descending aortic aneurysm repair before elec-
tive stent-graft repair of the AAA. The rationale to
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Table I. Maneuvers to facilitate device insertion/
navigation: results and complications
Procedural outcome Actual no. %
Incidence 35/50 70




Iliac artery rupture 0/15 0
Iliofemoral occlusion 0/15 0
perform bilateral internal iliac bypass grafts was to
minimize the potential neurologic sequelae from ces-
sation of arterial perfusion of the internal iliac artery. 
2. Subclavian artery transposition. In two patients
deployment of the thoracic endovascular device across
the origin of the left subclavian artery orifice was nec-
essary because of insufficient length for device implan-
tation. After, with the confirmation that the left
common carotid artery was free of significant occlu-
sive disease, subclavian artery transposition to the left
common carotid was performed before aneurysm
repair to preserve L upper extremity perfusion.
3. Elephant trunk type aortic arch repair used as a prox-
imal implantation site for endograft. In two patients
elephant trunk repair had been performed previously
for acute type A aortic dissections. Subsequently, both
patients went on to have large descending aortic
aneurysms necessitating intervention. In these cases
the graft material from the arch reconstruction was
used as a proximal implantation site or neck to anchor
the stent-graft.
4. Staged extra-anatomic visceral vessel reconstruction
and subsequent endovascular aortic grafting. Extra-
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anatomic bypass to superior mesenteric and renal
arteries was performed in one patient before the aor-
tic stent-graft repair. After a brief period of recovery
the thoracoabdominal aneurysm was performed with
exclusion of the aneurysm.
RESULTS
Fifty (12%) of the 390 patients undergoing endovas-
cular repair of their aneurysms required adjunctive surgi-
cal procedures. Thirty-five (70%) underwent procedures
to facilitate endovascular device delivery. Fifteen (30%)
required modification of the proximal or distal implanta-
tion sites. 
Facilitating endovascular device delivery. A summary
of results and specific complications is displayed in Table I.
All 35 procedures performed to facilitate device delivery
were performed in the iliofemoral vessels. These procedures
improved arterial access and permitted safe device navigation
in all cases. The mean follow-up for endovascular iliofemoral
interventions is 26 months. The mean follow-up for conduit
bypass graft procedures is 42 months. 
To date, all conduits remain patent. There were no
episodes of iliac artery rupture during device navigation.
Various supplemental procedures used to improve stent-graft navigational conditions in cases with different degrees of iliofemoral occlu-
sive disease. A, Schematic representation and preprocedural angiogram of endoluminal endarterectomy performed with multiple balloon
inflations and removal of plaques from femoral arteriotomy site by intermittent clamp release. B, Schematic of illustration and preinter-
vention and postintervention angiogram of an iliac artery stent graft used to allow subsequent safe balloon dilatations for extensive iliac
occlusive disease.
A B
Access site hematomas were diagnosed in five (14%) of the
35 patients. All hematomas were controlled by manual
compression of the access site. No patient required a
return to the operating room for a second intervention. 
Implantation site modification. A summary of results
and specific complications is displayed in Table II. One
patient who underwent subclavian artery transposition had a
new onset of Horner’s syndrome, which spontaneously
resolved 3 months postoperatively. No other peripheral
nerve injuries were associated with this procedure. 
Nine patients have undergone common iliac artery pli-
cation with a mean follow-up of 23 months. Two patients
went on to have retroperitoneal hematomas immediately
after the procedure that were not hemodynamically signif-
icant. None of these patients required surgical reinterven-
tions or blood transfusions. No symptoms of colonic
ischemia were seen after this procedure. At the time of this
report, no new onset of pseudoaneurysms or stump rup-
tures has been observed on follow-up imaging studies.
Two patients previously treated with the creation of an
elephant trunk graft for aortic dissection had descending
aortic aneurysms. One patient underwent successful stent-
graft repair by anchoring the proximal stent into the ele-
phant trunk graft. The second patient had bilateral
common iliac artery involvement by previous extension
from an aortic dissection with subsequent development of
aneurysm disease. Access to the iliofemoral arteries was
not possible in this case, which constitutes the only failure
of treatment on an “intent to treat” basis. The presence of
complex vascular anatomy in combination with severe
comorbidities in this frail patient precluded the perfor-
mance of any other auxiliary maneuvers.
One patient with an extra-anatomic reconstruction of
the visceral and renal vessels done before stent-graft repair
for a thoracoabdominal aneurysm needed to undergo
reexploration because of bleeding from the renal artery
ligation. Currently, this patient is alive and doing well.
DISCUSSION 
Because of its minimally invasive nature, endovascular
stent-grafting constitutes an important therapeutic option,
especially for the treatment of complex aortic disease.6
Endovascular treatment of arterial aneurysms requires
normal arterial segments immediately adjacent to the
aneurysmal area for adequate device anchoring. The pres-
ence of short-length attachment sites7 can complicate the
choice of a proximal implantation site, which can poten-
tially cause insufficient apposition of stent-graft to normal
arterial wall, compromising the longevity of the repair.
Wolf et al8 have published the eligibility rate of patients
with aortic aneurysms to have endovascular repair on the
basis of a large number of patients studied in the phase II
AneuRx trial published in this journal. Inadequate proxi-
mal implantation site was the main cause for excluding
patients for receiving endografting of AAA. However, in
interpreting the data, one must take into consideration the
fact that only one stent-graft was used in this cohort and
patients were strictly controlled by rigid inclusion criteria
of the trial. 
It is well-known that patients with AAAs or thoracic
aortic aneurysms have other concomitant arterial diseases
that may complicate or even exclude them from receiving
endovascular stent-graft therapy.9-12 Distal implantation
sites can be problematic in the presence of common iliac
artery aneurysms, which not only complicate the selection
for an adequate implantation site but also present a chal-
lenge as to how to preserve the internal iliac arteries and
prograde pelvic flow.13 Henretta et al14 have also reported
their incidence of significant coexisting occlusive diseases
of the access vessels, especially in regard to the iliofemoral
segments, in 74 patients treated for aortic aneurysms with
endovascular stent-grafting. Currently, the incidence of
significant coexistent arterial disease initially impeding
endovascular repair of their aortic aneurysms is unknown. 
Coexisting atherosclerosis in the iliofemoral system is
the most common problem encountered in these patients,
which is also the most common access site used for device
insertion. When an access site is chosen, the arteries must
be relatively free of disease, thus allowing navigation of the
delivery system through them to the aneurysmal aorta.
However, currently available devices have large and non-
steerable delivery systems, which can cause iliofemoral
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Table II. Implantation site modification: results and complications
Actual no. % Treatment and outcome
Incidence 15/50 30
Device implantation success rate 14/15 93
Complications
Subclavian artery transposition 1 patient with Self-limited, no medication
Horner’s syndrome 
Common iliac ligation 2 patients with Blood transfusion, 
retroperitoneal hematoma no exploration needed
Elephant trunk 1 patient with preexistent Device insertion not performed,
aorta dissection extending procedure aborted
to iliac arteries
Viscero-renal bypass graft 1 patient with Renal artery stump repaired
retroperitoneal hematoma at reexploration
injuries during insertion of the device at a rate of 5% to
17%.15-18 Most of these patients did not have significant
iliofemoral disease identified before the endovascular
intervention. Because a significant number of elderly
patients with advanced atherosclerotic disease are treated
with this therapeutic modality, access and navigational
problems will become even more apparent as one of the
main initial impediments to patient eligibility. Two of the
main goals of this study were to characterize the various
types of arterial disease involving the access arterial sites
and to describe the specific supplemental interventions
performed to ameliorate each of these lesions to allow safe
stent-grafting of aortic aneurysms. 
In our study, 35, or 6% of patients with aortic
aneurysms had significant iliofemoral arterial disease,
which required supplemental interventions to permit safe
navigation of the delivery system. Several modalities were
used in the treatment of the iliofemoral disease, including
balloon angioplasty, endarterectomies, and the construc-
tion of extraluminal and endoluminal conduits to facilitate
device navigation. 
The simplest treatment modality for focal iliac artery
stenosis is balloon angioplasty, which can sufficiently dilate
the vessel to allow the device to safely traverse the lesion.
This was used in eight of the 35 patients. After stent-graft
deployment, stenting can be performed to prevent recoil-
ing of the lesion. Iliac stents were not placed before stent-
graft insertion in this series because of the theoretical risk
of the stent migration during the insertion of the delivery
system. 
Several supplemental maneuvers were used to correct
more complex iliofemoral lesions. For mildly calcified
arteries with significant tortuosity, digital dissection
allowed full exposure and straightening of the redundant
external iliac artery, thus decreasing the potential risk of
perforation by the delivery system. Frequently, the iliac
arteries are diffusely stenotic. Closed endarterectomy can
be performed in these stenotic vessels with multiple seg-
mental balloon dilations throughout the diseased seg-
ments. With the use of this technique, atherosclerotic
debris is extracted from the femoral arteriotomy site. For
patients with iliac arteries free of tortuosity but with long,
circumferential, nearly occlusive disease, intraluminal
iliofemoral bypass grafts were used to permit dilation of a
long stenotic segment of the iliac artery. This supplemen-
tal maneuver eliminates the risk of iliac artery rupture by
inadvertent angioplasty, because the severely diseased ves-
sel is protected by the intraluminal bypass graft. The com-
bination of severe occlusive disease with tortuosity can
represent one of the most extreme disease presentations in
the iliac artery system. For these patients, the entire dis-
eased iliac segment was avoided by allowing device navi-
gation through an extraluminal iliofemoral bypass
conduit, which was constructed through a retroperitoneal
approach. 
Successful endovascular repair of aortic aneurysms
requires exclusion of the aneurysmic sac from the main
arterial circulation by the stent-graft. Adequate proximal
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and distal implantation sites must be present to allow the
device attachment mechanisms to anchor at these sites to
ensure long-term repair durability. Insufficient length of a
normal-caliber artery or accentuated angulations of the
implantation site may make endovascular repair impossi-
ble. Ancillary procedures that were performed to allow
implantation of the endovascular device can be conceptu-
ally subdivided into (1) procedures applied directly on the
implantation site to enhance arterial anatomy and (2) pro-
cedures that allowed relocation of the implantation site to
a more favorable anatomy. 
For AAAs extending into the iliac arteries, endovascu-
lar repair may be performed with an aortouniiliac device.
An occluder device is used to prevent aneurysm perfusion
through the contralateral common iliac artery after a con-
struction of a femorofemoral bypass graft to establish cir-
culation to the contralateral lower extremity. However,
this approach is not feasible when both common iliac
arteries are aneurysmal. In our series, 11 patients had
bilateral coil embolization of their internal iliac arteries to
allow device deployment into the external iliac arteries dis-
tal to the iliac aneurysms. This maneuver carried an inci-
dence of pelvic ischemia as high as 51%.14 Thus, it has
been our policy to preserve at least one of the internal iliac
arteries by performing ligation with subsequent discon-
nection of one common iliac artery at the iliac bifurcation
to preserve pelvic circulation from the remaining internal
iliac artery. This supplemental procedure makes the
anatomy suitable for treatment with an aortouniiliac or
femoral device. In these cases, both arterial stumps are
oversewn with reinforcing pladgets. No signs of stump
pseudoaneurysm have been detected in these patients;
however, continued observation is needed to assess the
integrity of the remnant common iliac artery stump.
Recently, our preferred method of preserving prograde
pelvic arterial flow is by relocating the internal iliac artery
inflow to a segment of the external iliac artery, as
described by Parodi and Ferreira.5
Another supplemental technique that was used to treat
a large thoracoabdominal aneurysm involved the con-
struction of an extra-anatomic renovisceral bypass graft to
allow ligation of these vessels. This maneuver can simplify
the operative strategy in patients who require reoperations
by avoiding technical difficulties of exposing the aorta. In
addition, viscero-renal ischemia does not occur, thus
reducing the overall cardiovascular disturbances and end-
organ ischemia. After recovery from this initial staged
treatment, a stent-graft was deployed to treat a long-
segment aorta involved by aneurysm with inconsequential
graft coverage of otherwise essential aortic branches. 
Subclavian artery transposition was used in patients
whose thoracic aneurysms began close to the subclavian
artery. In two cases in which this supplemental technique
was performed the endovascular stent-graft covered the
original orifice of the artery to ensure sufficient apposition
of the stent-graft to the proximal neck. The patency rate
for occlusive lesions of these vessels treated by construct-
ing subclavian-carotid bypass grafts carries an excellent
long-term patency as described by Berguer and Kline.19
Thus, one would expect comparable results in a similar
patient cohort. 
The use of an “elephant trunk” graft as proximal
implantation site for an endograft has been described by
Fann et al.20 Two patients with such anatomy are included
in this study. Although deployment of a device was suc-
cessful in one patient, a second patient had aortic dissec-
tion from the aorta extending to iliac arteries bilaterally
with subsequent aneurysmal degeneration of these vessels.
This patient constitutes the only failure on the intent to
treat basis. Accessing these vessels was not possible for
technical reasons, and the patient’s overall medical condi-
tion precluded any other ancillary maneuver. Although the
tensile strength of a graft should be adequate to serve as
an attachment site for an endograft, cautious long-term
follow-up is necessary because of a lack of clinical data at
this moment.
This study constitutes data compiled from a referral
center for endovascular aortic repair and perhaps repre-
sents a higher incidence of cases with difficult anatomies
when compared with a general vascular practice. We think
that the principal element for successful endovascular
repair of aortic aneurysms with difficult anatomy is the
combination of prompt identification of an arterial lesion
to prevent iatrogenic injuries before the aneurysm repair
by stent-graft exclusion. As technology advances, in the
future, devices will have the capability to negotiate many
of the secondary arterial lesions described in this report.
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Dr O. William Brown (Southfield, Mich). I certainly want to
congratulate you on some of these most innovative techniques in
facing these very difficult problems. I guess my question would
be, certainly in high-risk patients with a great deal of medical
problems, we would use these. Have you extended this now to try
to use these techniques, such as an iliofemoral graft, in all patients
regardless of their preoperative medical status?
Dr Osvaldo Yano. I think that is a very broad question. It
goes back to technology, if the repairs are durable or not. I think
that is a topic of its own right there. We have used actually
retroperitoneal approaches and iliofemoral bypass constructions
for patients who had small access vessels. The vessels do not have
to be necessarily diseased, but if you have a thoracic aneurysm and
because the stent-graft device is quite large and if you have some-
what small iliac vessels, the stent-graft device may not be able to
pass safely. Dr Hollier’s philosophy is to go ahead and operate in
patients who have very low medical comorbidities and reserve
aortic-endografts for the high-risk patient population. Just last
week we removed a stent-graft because the distal graft migrated,
and that was 3 years after repair. Clearly, durability at this point is
the main issue with technology.
Dr Roy Greenberg (Cleveland, Ohio). I enjoyed your paper,
and we actually share many of your beliefs in terms of how to
manipulate the iliac arteries prior to or during an endovascular
repair. My question relates to the timing of changing your
approach. Our feeling is that when we start on the procedure, our
DISCUSSION
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first shot is our best shot. Otherwise, if we damage the iliac artery
while we are trying to do an endovascular repair, you are back-
pedaling, and your ability to save a hypogastric artery or do
another procedure is lost. Are you attaching a conduit for most of
these procedures, or are you deploying another stent-graft so that
you can angioplasty the iliac system with impunity? Are you per-
forming this procedure as a planned procedure, to be done prior
to attempted passage of the stent-graft, or is it being performed
as a bailout procedure when you cannot pass your device safely
through the iliac arteries? 
Dr Yano. As you can see the anatomies that we showed in this
presentation have quite severe occlusion and tortuosity associated
with the access vessels. All of these maneuvers were done before any
problems happened. I think that is the key message of this talk. If
you have a patient who had coexistent severe arterial disease, num-
ber one, you should know the anatomy, and number two, you
should know the limitation of the device. If the device is not steer-
able and you know that, you should not go ahead and push the
device capabilities to negotiate a very tortuous occlusive disease ves-
sel. You should go ahead and do this before you have a problem.
